Asset Details
Do you wish to reserve the book?
MSGene: a multistate model using genetic risk and the electronic health record applied to lifetime risk of coronary artery disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
MSGene: a multistate model using genetic risk and the electronic health record applied to lifetime risk of coronary artery disease
Do you wish to request the book?
MSGene: a multistate model using genetic risk and the electronic health record applied to lifetime risk of coronary artery disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
MSGene: a multistate model using genetic risk and the electronic health record applied to lifetime risk of coronary artery disease
2024
Overview
Coronary artery disease (CAD) is the leading cause of death among adults worldwide. Accurate risk stratification can support optimal lifetime prevention. Current methods lack the ability to incorporate new information throughout the life course or to combine innate genetic risk factors with acquired lifetime risk. We designed a general multistate model (MSGene) to estimate age-specific transitions across 10 cardiometabolic states, dependent on clinical covariates and a CAD polygenic risk score. This model is designed to handle longitudinal data over the lifetime to address this unmet need and support clinical decision-making. We analyze longitudinal data from 480,638 UK Biobank participants and compared predicted lifetime risk with the 30-year Framingham risk score. MSGene improves discrimination (C-index 0.71 vs 0.66), age of high-risk detection (C-index 0.73 vs 0.52), and overall prediction (RMSE 1.1% vs 10.9%), in held-out data. We also use MSGene to refine estimates of lifetime absolute risk reduction from statin initiation. Our findings underscore our multistate model’s potential public health value for accurate lifetime CAD risk estimation using clinical factors and increasingly available genetics toward earlier more effective prevention.
Coronary artery disease is the leading cause of death among adults worldwide, however current risk stratification methods lack the ability to incorporate new information throughout the life-course or to combine innate genetic risk factors with acquired lifetime risk. Here the authors introduce a multistate model to address these limitations.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Adult
/ Adults
/ Aged
/ Coronary Artery Disease - epidemiology
/ Coronary Artery Disease - genetics
/ Electronic Health Records - statistics & numerical data
/ Female
/ Genetic Predisposition to Disease
/ Genetics
/ Humanities and Social Sciences
/ Humans
/ Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
/ Male
/ Multifactorial Inheritance - genetics
/ Science
